Brett Tindall

1.8k total citations
27 papers, 1.1k citations indexed

About

Brett Tindall is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Brett Tindall has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 13 papers in Epidemiology and 12 papers in Virology. Recurrent topics in Brett Tindall's work include HIV/AIDS Research and Interventions (17 papers), HIV Research and Treatment (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Brett Tindall is often cited by papers focused on HIV/AIDS Research and Interventions (17 papers), HIV Research and Treatment (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Brett Tindall collaborates with scholars based in Australia, United States and Netherlands. Brett Tindall's co-authors include David A. Cooper, Ronald Penny, Andrew Carr, Deborah Marriott, John Harkness, Michael Marmor, Bruce J. Brew, Geoffrey Berry, Joyce L. Burcham and Cheryl E. Swanson and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and American Journal of Epidemiology.

In The Last Decade

Brett Tindall

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett Tindall Australia 17 734 590 505 123 120 27 1.1k
G. Vercauteren Belgium 16 573 0.8× 495 0.8× 385 0.8× 88 0.7× 139 1.2× 25 929
S. M. Burns United Kingdom 19 450 0.6× 217 0.4× 873 1.7× 101 0.8× 96 0.8× 51 1.4k
Diana Antoniskis United States 14 1.1k 1.5× 290 0.5× 964 1.9× 79 0.6× 138 1.1× 20 1.6k
Roel A. Coutinho Netherlands 19 627 0.9× 616 1.0× 540 1.1× 82 0.7× 147 1.2× 27 1.1k
J Carswell Uganda 12 529 0.7× 197 0.3× 316 0.6× 163 1.3× 53 0.4× 30 919
Ronan Doorly United States 10 618 0.8× 214 0.4× 462 0.9× 73 0.6× 68 0.6× 10 882
Giovanni Rezza Italy 22 1.1k 1.5× 637 1.1× 553 1.1× 90 0.7× 160 1.3× 47 1.6k
Josep M. Gatell Spain 22 991 1.4× 575 1.0× 780 1.5× 59 0.5× 66 0.6× 61 1.6k
Josep M. Miró Spain 18 560 0.8× 209 0.4× 438 0.9× 51 0.4× 77 0.6× 39 877
Marshall Munjoma Zimbabwe 19 394 0.5× 214 0.4× 390 0.8× 176 1.4× 72 0.6× 35 875

Countries citing papers authored by Brett Tindall

Since Specialization
Citations

This map shows the geographic impact of Brett Tindall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Tindall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Tindall more than expected).

Fields of papers citing papers by Brett Tindall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Tindall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Tindall. The network helps show where Brett Tindall may publish in the future.

Co-authorship network of co-authors of Brett Tindall

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Tindall. A scholar is included among the top collaborators of Brett Tindall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Tindall. Brett Tindall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veugelers, Paul J., Steffanie A. Strathdee, Andrew R. Moss, et al.. (1995). Is the Human Immunodeficiency Virus -Related Kaposiʼs Sarcoma Epidemic Coming to an End? Insights from the Tricontinental Seroconverter Study. Epidemiology. 6(4). 382–386. 16 indexed citations
2.
Hirschel, Bernard, Bruno Hoen, David A. Cooper, et al.. (1995). A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection. New England Journal of Medicine. 333(7). 408–413. 218 indexed citations
3.
Swanson, Cheryl E., Brett Tindall, & David A. Cooper. (1994). Efficacy of zidovudine treatment in homosexual men with AIDS-related complex. AIDS. 8(5). 625–634. 12 indexed citations
4.
Dubin, Neil, Simeon M. Berman, Michael Marmor, et al.. (1994). Estimation of time since infection using longitudinal disease‐marker data. Statistics in Medicine. 13(3). 231–244. 4 indexed citations
5.
Veugelers, Paul J., Kimberly Page, Brett Tindall, et al.. (1994). Determinants of HIV Disease Progression among Homosexual Men Registered in the Tricontinental Seroconverter Study. American Journal of Epidemiology. 140(8). 747–758. 75 indexed citations
6.
Veugelers, Paul J., Martin T. Schechter, Brett Tindall, et al.. (1993). Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual men. AIDS. 7(10). 1325–1330. 30 indexed citations
7.
Tindall, Brett, et al.. (1993). Development of AIDS in people with transfusion-acquired HIV infection. AIDS. 7(7). 1009–1014. 27 indexed citations
8.
Carr, Andrew, Brett Tindall, Bruce J. Brew, et al.. (1992). Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS. Annals of Internal Medicine. 117(2). 106–111. 163 indexed citations
9.
Carr, Andrew, Brett Tindall, Ronald Penny, & David A. Cooper. (1992). Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. AIDS. 6(2). 165–172. 32 indexed citations
10.
Tindall, Brett, et al.. (1992). Identification of HIV-1 in semen following primary HIV-1 infection. AIDS. 6(9). 949–952. 41 indexed citations
11.
Burcham, Joyce L., Michael Marmor, Neil Dubin, et al.. (1991). CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS. 5(4). 365–372. 80 indexed citations
12.
Tindall, Brett, Hans Gaines, Allison Imrie, et al.. (1991). Zidovudine in the management of primary HIV-1 infection. AIDS. 5(5). 477–484. 45 indexed citations
13.
Tindall, Brett & David A. Cooper. (1991). Primary HIV infection. AIDS. 5(1). 1–14. 107 indexed citations
14.
Tindall, Brett, Cheryl E. Swanson, & David A. Cooper. (1990). Development of AIDS in a cohort of HIV‐seropositive homosexual men in Australia. The Medical Journal of Australia. 153(5). 260–265. 12 indexed citations
15.
Sanson‐Fisher, Rob, C Bridges‐Webb, Rosemary Coates, et al.. (1990). Attitudes, knowledge and behaviour of general practitioners ir relation to HIV infection and AIDS: Commonwealth AIDS Research Grant Committee Working Party. The Medical Journal of Australia. 153(1). 5–12. 16 indexed citations
16.
Tindall, Brett, et al.. (1990). HIV-related sicrimination. AIDS. 4(Supp 1). S257–S257. 3 indexed citations
17.
Tindall, Brett, et al.. (1989). Malignant melanoma associated with human immunodeficiency virus infection in three homosexual men. Journal of the American Academy of Dermatology. 20(4). 587–591. 34 indexed citations
18.
Tindall, Brett, et al.. (1989). Severe clinical manifestations of primary HIV infection. AIDS. 3(11). 747–750. 42 indexed citations
19.
Burcham, Joyce L., Geoffrey Berry, Brett Tindall, et al.. (1989). Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. The Medical Journal of Australia. 150(11). 634–639. 64 indexed citations
20.
Tindall, Brett, David A. Cooper, Basil Donovan, & Ronald Penny. (1988). Primary Human Immunodeficiency Virus Infection. Infectious Disease Clinics of North America. 2(2). 329–342. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Vercauteren Breakdown of academic impact, for papers by S. M. Burns Breakdown of academic impact, for papers by Diana Antoniskis Breakdown of academic impact, for papers by Roel A. Coutinho Breakdown of academic impact, for papers by J Carswell Breakdown of academic impact, for papers by Ronan Doorly Breakdown of academic impact, for papers by Giovanni Rezza Breakdown of academic impact, for papers by Josep M. Gatell Breakdown of academic impact, for papers by Josep M. Miró Breakdown of academic impact, for papers by Marshall Munjoma
Rankless by CCL
2026